Home » Newsletters » BioWorld Science

BioWorld Science

March 28, 2002

View Archived Issues

Johnson & Johnson to acquire all assets of Tibotec-Virco

New controlled release oral morphine product receives regulatory approval in Canada

Nobex and Pharmacia collaborate on oral protein drug delivery

Amrad ceases further development of emfilermin for chemotherapy-induced peripheral neuropathy

Aventis and Eisai to copromote Actonel in Japan

Phase I clinical trials of Genexol-PM commence in patients with refractory cancer

Calcium-sensing receptor modulators described in a recent CNRS patent

New antitumor compounds from marine sponge synthesized at the University of Barcelona

Ortho-McNeil claims new series of neuroprotective derivatives

Steroid derivatives useful for treating a number of neurodegenerative diseases identified at Kyorin

Angiotensin II antagonists jointly reported by Asahi Glass and Mitsubishi Pharma

ProusNet Channel 1 presents Orphan G-Protein Coupled Receptors

European Commission grants marketing approval for Arixtra

Dynepo receives E.U. approval for anemia of renal failure

Cellegy commences phase II/III trial of Tostrelle for treatment of FSD

ISTA reports preliminary phase III results for Vitrase

Keiten marketing rights transfer from Chugai to Fujisawa

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...